Use of Extracorporeal Membrane Oxygenation for Patients with Coronavirus Disease 2019 Infection

Jessica M Ruck; Errol L Bush

doi:10.1016/j.yasu.2024.05.003

Use of Extracorporeal Membrane Oxygenation for Patients with Coronavirus Disease 2019 Infection

Adv Surg. 2024 Sep;58(1):249-273. doi: 10.1016/j.yasu.2024.05.003. Epub 2024 Jun 29.

Authors

Jessica M Ruck¹, Errol L Bush²

Affiliations

¹ Division of Thoracic Surgery, Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
² Division of Thoracic Surgery, Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD, USA. Electronic address: [email protected].

PMID: 39089781
PMCID: PMC11294677 (available on 2025-09-01)
DOI: 10.1016/j.yasu.2024.05.003

Abstract

The coronavirus disease 2019 (COVID-19) pandemic was a cataclysmic event that infected over 772 million and killed over 6.9 million people worldwide. The pandemic pushed hospitals and society to their limits and resulted in incredibly severe respiratory disease in millions of people. This severe respiratory disease often necessitated maximum medical therapy, including the use of extracorporeal membrane oxygenation. While our understanding of COVID-19 and its treatment continue to evolve, we review the current evidence to guide the care of patients with severe COVID-19 infection.

Keywords: COVID-19; Cardiac failure; Coronavirus; Extracorporeal membrane oxygenation; Respiratory failure; VV ECMO.

Publication types

Review

MeSH terms

COVID-19* / epidemiology
COVID-19* / therapy
Extracorporeal Membrane Oxygenation*
Humans
Pandemics
SARS-CoV-2

Grants and funding

F32 AG067642/AG/NIA NIH HHS/United States